About Us
The Center for Chemical Genomics provides high-throughput screening of extensive small molecule, natural product and siRNA libraries — along with assay development and optimization — for basic biology and drug discovery projects.
Our dedicated staff has years of experience in academic drug discovery and within the pharmaceutical industry, allowing us to provide expert guidance to researchers through every stage of a project.
Our services are available to U-M researchers and to outside academic and industry partners.
If you're a new user, please visit our getting started guide.
Announcements
The CCG has reopened on a limited basis. Our staff is available to assist with both internal and external projects. Please reach out to lsi-screening@umich.edu with questions.
Based on direction from the University of Michigan leadership, the Center for Chemical Genomics will be closed effective Friday, March 20 at 5:00 p.m.
While our services that require in-lab work will be unavailable, we remain available to assist you with remote work as possible, including:
· consultations and project planning
· bioinformatics work
· support letters
· services for COVID-19 research
The Dart collection is now part of the extended CCG library available for immediate screening and purchase. Please contact the Center for Chemical Genomics to get more information.
Our Services
We offer high-throughput screening of extensive small molecule, natural product and siRNA libraries — along with assay development and optimization — for basic biology and drug discovery projects.
We have more than 240,000 diverse small molecule compounds, a unique library of more than 42,000 natural product extracts, an extensive siRNA library and a growing library of FDA-approved compounds for drug repurposing projects.
Explore MScreen, a cost-effective, web-based data storage and analysis tool we developed to help users streamline the hit-to-lead decision process.
CGG Seminar Series
The center hosts regularly seminars on topics related to high-throughput screening. Please join us.
Publication Acknowledgments
Please remember to acknowledge the center in research publications that relied on our services.
Featured News
New research clarifies how ‘fuzzy’ proteins can be used to develop novel drugs
Researchers have determined how to target a class of proteins that have long been considered too “fuzzy” to target with small molecules, opening the door to new drug-discovery projects.
Michigan Medicine enters drug discovery collaboration with AstraZeneca in Chronic Kidney Disease
Patients with Chronic Kidney Disease may benefit from a new collaboration between U-M and AstraZeneca, who have partnered to develop a new therapeutic strategy for treatment.
Repurposed asthma drug shows blood sugar improvement among some diabetics
After 12 weeks of taking an anti-asthma drug, a subset of patients with type 2 diabetes showed a clinically significant reduction in blood glucose during a clinical trial.